Labarai

VANCOUVER, BC, Fabrairu 22, 2023 /PRNewswire/ — Kasuwar duniya mai motsa ci gaban ƙashi tana da darajar dala biliyan 2.22 a shekarar 2022 kuma ana sa ran za ta girma a CAGR na 5.5% a tsawon lokacin hasashen. bincike mai tasowa. Ci gaban kudaden shiga a kasuwar masu motsa ci gaban ƙashi yana faruwa ne sakamakon karuwar kamuwa da karaya da cututtukan ƙashi, karuwar bukatar magunguna marasa cutarwa da marasa ciwo, da kuma karuwar yawan tsofaffi.
Nemi kwafin samfurin kyauta (koyi cikakken tsarin wannan rahoton [taƙaitawa + teburin abubuwan da ke ciki]) @ https://www.emergenresearch.com/request-sample/1373
Ƙaruwar yawan karyewar ƙashi da cututtukan ƙashi kamar osteoporosis da osteoarthritis na ɗaya daga cikin manyan abubuwan da ke haifar da ƙaruwar kuɗaɗen shiga kasuwa. A duk duniya, ɗaya cikin mata uku da ɗaya cikin maza biyar da suka haura shekaru 50 suna fuskantar karyewar ƙashi, a cewar Gidauniyar Ƙasa da Ƙasa ta Osteoporosis. Bugu da ƙari, ƙaruwar yawan tsofaffi yana da saurin kamuwa da karyewar ƙashi, wanda ake sa ran zai ƙara buƙatar magungunan ƙarfafa ƙashi. Bugu da ƙari, buƙatar magungunan da ba sa haifar da illa ga ƙashi da kuma waɗanda ba sa haifar da ciwo yana haifar da gabatar da magungunan ƙarfafa ƙashi domin suna ba da ingantaccen zaɓi na magani ba tare da tiyata ba don magance karyewar ƙashi da cututtuka.
Tsadar farashin magungunan ƙarfafa ƙashi yana ɗaya daga cikin manyan abubuwan da ke hana ci gaban kasuwar ƙarfafa ƙashi. Tsadar waɗannan na'urori yana iyakance rarraba su, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi inda farashin kiwon lafiya babban abin damuwa ne. Bugu da ƙari, rashin wayar da kan jama'a da ƙarancin manufofin biyan diyya a wasu yankuna suma manyan cikas ne ga ci gaban kasuwa.
Ana sa ran kasuwar duniya mai motsa ci gaban ƙashi za ta cimma CAGR na 5.5% a lokacin hasashen, inda kudaden shiga ke ƙaruwa daga dala biliyan 2.22 a shekarar 2022 zuwa dala biliyan 3.80 a shekarar 2032. Ci gaban kasuwar yana da alaƙa da ƙaruwar yawan karyewar ƙashi da cututtuka, ƙaruwar yawan tsofaffi da kuma buƙatar magunguna marasa cutarwa da marasa ciwo.
Emergen Research na bayar da rangwame na ɗan lokaci (sami kwafin ku yanzu akan farashi mai rahusa) @ https://www.emergenresearch.com/request-discount/1373
Kasuwar magungunan ƙarfafa ƙashi tana fuskantar manyan canje-canje a lokacin hasashen. A halin yanzu akwai wani yanayi na haɓaka sabbin magungunan ƙarfafa ƙashi da aka inganta waɗanda za a iya amfani da su a cikin ayyukan tiyata daban-daban. An tsara waɗannan sabbin na'urori don su fi inganci, daidaito da kuma amfani da na'urori na gargajiya. Bugu da ƙari, akwai yanayin amfani da magungunan ƙarfafa ƙashi a cikin sabbin hanyoyin zamani kamar tiyatar haɗa ƙashi, hanyar tiyata da ake amfani da ita don magance karyewar ƙashi da cututtuka na kashin baya.
Manyan kamfanonin da aka haɗa a cikin rahoton kasuwa sune Isto Biologics, JOHNSON da Johnson, MEDTRONIC PLC., Orthofix Medical Inc., STRYKER CORPORATION, Terumo Corporation, ZIMMER BIOMET HOLDINGS, IGEA Pharma, Manamed Inc. da THERAGEN ETEX CO., LTD.
Waɗannan kamfanoni suna da hannu dumu-dumu a cikin shirye-shiryen dabaru kamar M&A, haɗin gwiwa da haɗin gwiwa don faɗaɗa fayil ɗin samfuran su da ƙarfafa kasancewar kasuwar su. Misali, a watan Satumba na 2022, Bioventus LLC ta sanar da sayen Emerge Medical, wani kamfani wanda ke samar da ingantattun samfuran kula da rauni da maganin matsewa, don faɗaɗa fayil ɗin samfuran kashin baya da na biosurgical.
Duba Cikakken Bayanin Rahoton + Hanyar Bincike + Abubuwan da ke Ciki + Bayanan Bayani @ https://www.emergenresearch.com/industry-report/bone-growth-stimulator-market
Amurka, Kanada, Mexico, Jamus, Faransa, Birtaniya, Italiya, Spain, Benelux, Sauran Turai, China, Indiya, Japan, Koriya, Sauran Asiya Pacific, Brazil, Sauran Latin Amurka, Saudi Arabia, Hadaddiyar Daular Larabawa, Afirka ta Kudu, Turkiyya, Sauran Gabas ta Tsakiya da Afirka
Orthofix US LLC, Stryker, Medical Device Business Services, Inc., Bioventus, Medtronic, DJO, LLC, Zimmer Biomet, Arthrex, Inc., Kamfanin Terumo, Ossatec Benelux BV
Ana iya buƙatar buƙatun keɓancewa don wannan rahoton [na musamman] @ https://www.emergenresearch.com/request-for-customization/1373
Don dalilan wannan rahoton, Emergen Research ta raba kasuwar Kashi ta Duniya ta Ƙwayoyin Ƙashi bisa ga samfur, aikace-aikace, amfani da ƙarshen amfani da yanki:
Kasuwar Tsarin Kwantena Mai Tsaftacewa ta Nau'in Samfura (Tsarin Kwantena Mai Tsaftacewa Mai Rami, Sauran), Fasaha, Nau'in Kayan Aiki (Aluminum, Bakin Karfe, Roba, Sauran), Yankuna. Hasashen har zuwa 2032
Kasuwar Shuka Mai Daidaito ta Kayayyaki da Ayyuka (Kayan Aiki, Software, Sauran), Fasaha (Fasaha ta Ƙasa, Fasahar Jiragen Sama), Nau'in Tsarin, Aikace-aikacen (Hatsi, Irin Mai & Ƙwayoyin Hatsi, Sauran), Hasashen Yankin zuwa 2032
Kasuwar Faci ta Insulin Mai Wayo ta Samfura (Sa ido kan Faci da Faci na Transdermal), ta Amfani da Ƙarshe (Asibitoci, Gidajen Kula da Gida, Asibitoci), ta Yankin. Hasashen har zuwa 2032
Kasuwar Sutures ta samfura, ta nau'i, ta hanyar amfani (tiyatar zuciya, tiyatar gabaɗaya, tiyatar mata, tiyatar kashin baya, da sauransu), ta hanyar amfani da ƙarshen lokaci da kuma yanki. Hasashen har zuwa 2032
Kasuwar tayoyi ta waje ta nau'in kayan aiki, ta hanyar samar da wutar lantarki, ta nau'in kayan aikin masana'antu, ta nau'in taya, ta girman rim, ta hanyar amfani (kayan gini da haƙar ma'adinai, taraktocin noma da kayan aikin masana'antu), da kuma ta yanki. Hasashen har zuwa 2032
Kasuwar Famfon Jiko ta Nau'i (Mai Kyau, Sirinji, Elastomeric, Insulin, Ciki da kuma wanda za a iya dasawa), Amfani (Ciwon Suga, Ciwon Kanjamau da Kula da Ciwo), Amfani da Ƙarshe da Yankin. Hasashen har zuwa 2030
Kasuwar Tsarin Tsaron Ruwa ta Tsarin (Tsarin Rahoton Tsaron Jiragen Ruwa, Tsarin Ganowa ta atomatik, Tsarin Bin Diddigin Nesa da Ganowa, da sauransu), ta Aikace-aikacen, ta Mai Amfani na Ƙarshe, ta Yankin. Hasashen har zuwa 2032
Haɓaka kasuwar ganowa da amsawa ta hanyar sassa (mafita da ayyuka), ta hanyar tura (gajimare da kuma a cikin gida), ta girman ƙungiya, ta tsaye, da kuma ta yanki. Hasashen har zuwa 2032
Kasuwar asali mai rarrabawa ta nau'in asali (biometric vs. non-biometric), ta girman ƙungiya (SMB vs. babban kamfani), ta amfani da ƙarshe (na mutum da na kamfani), ta tsaye, ta yanki. Hasashen har zuwa 2032
Kasuwar isar da kiwon lafiya ta hanyar fasaha ta hanyar samfuri (kula da gaggawa ta kama-da-wane da asibiti na gida), ta nau'in, ta ƙwarewa, ta hanyar kulawa, ta mai amfani da ƙarshe da kuma ta yanki, an yi hasashen zuwa 2032
Emergen Research kamfani ne na bincike da ba da shawara wanda ke ba da rahotannin bincike na haɗin gwiwa, rahotannin bincike na musamman, da ayyukan ba da shawara. Maganganun mu sun fi mayar da hankali kan manufofin ku na gano, ganowa da kuma nazarin canje-canje a cikin halayen masu amfani bisa ga alƙaluma da masana'antu, da kuma taimaka wa abokan ciniki su yanke shawara mafi kyau game da kasuwanci. Muna gudanar da bincike a kasuwa, muna samar da bincike na zamani da kuma shaidu a fannoni daban-daban, ciki har da kiwon lafiya, wuraren taɓawa, sinadarai, nau'ikan, da makamashi. Muna sabunta kayayyakin bincikenmu akai-akai don ci gaba da sanar da abokan cinikinmu sabbin yanayin kasuwa. Emergen Research yana ɗaukar ƙwararrun masu nazari daga fannoni daban-daban na ƙwararru. Kwarewarmu a fannin masana'antu da ikonmu na haɓaka takamaiman mafita don kowane ƙalubalen bincike yana ba abokan cinikinmu damar samun fifiko a kan masu fafatawa da su.